DEA to Hold Hearing on Proposed Schedule I Placement of 2,5-Dimethoxy-4-Iodoamphetamine (DOI) and 2,5-Dimethoxy-4-Chloroamphetamine (DOC)

Summary

The Drug Enforcement Administration will conduct a hearing to consider the proposed placement of DOI and DOC, two phenethylamine hallucinogens, in Schedule I of the Controlled Substances Act, as part of a proposed rule.